2024 annual financial data

Autolus Therapeutics 2024 Net margin

Direct answer

Net margin was -2,180.45%.

Operating income was -241.43M USD and net income was -220.66M USD.
Operating cash flow was -206.27M USD.

Get free Autolus Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10.12M USD
Operating income
-241.43M USD
Net income
-220.66M USD
Operating cash flow
-206.27M USD